Literature DB >> 632355

Lymphocyte transformation in cancer patients: variation in results according to technique.

G M Gyte, S M Watkins.   

Abstract

Lymphocyte transformation to phytohaemagglutinin (PHA) was measured simultaneously by two methods (heparin and methyl cellulose) in 16 patients with non-lymphoid cancer and 21 normal subjects. Twelve cancer patients showed transformation levels below the normal heparin range, but only two patients showed levels below the normal methyl cellulose range. These findings suggest that in interpreting lymphocyte transformation studies close attention should be given to the methods employed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632355      PMCID: PMC1145201          DOI: 10.1136/jcp.31.2.125

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

1.  Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.

Authors:  T Nemoto; T Han; J Minowada; V Angkur; A Chamberlain; L Dao
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

2.  An immunosuppressive peptide fraction in the serum of cancer patients.

Authors:  A H Glasgow; J O Menzoian; R B Nimberg; S R Cooperband; K Schmid; J A Mannick
Journal:  Surgery       Date:  1974-07       Impact factor: 3.982

3.  Reduction of lymphocyte transformation by a factor produced by gastrointestinal cancer.

Authors:  A J Edwards; G F Rowland; M R Lee
Journal:  Lancet       Date:  1973-03-31       Impact factor: 79.321

4.  The effect of immunoregulatory globulin (IRA) upon lymphocytes in vitro.

Authors:  S R Cooperband; A M Badger; R C Davis; K Schmid; J A Mannick
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

5.  Cancer, immunological surveillance, and 2 -globulin.

Authors:  R J Ablin
Journal:  Lancet       Date:  1972-10-21       Impact factor: 79.321

6.  Serum inhibitors of lymphocyte responses.

Authors:  R A Gatti
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

7.  Alpha-2-globulins in renal graft rejection. Effects of in vitro lymphocyte function.

Authors:  R R Riggio; G H Schwartz; F G Bull; K H Stenzel; A L Rubin
Journal:  Transplantation       Date:  1969-11       Impact factor: 4.939

8.  Lymphocyte response to P.H.A. in patients with non-lymphoid tumours.

Authors:  D B Garrioch; R A Good; R A Gatti
Journal:  Lancet       Date:  1970-03-21       Impact factor: 79.321

9.  The delayed hypersensitivity reaction in breast cancer.

Authors:  M M Roberts; W Jones-Williams
Journal:  Br J Surg       Date:  1974-07       Impact factor: 6.939

10.  Phytohemagglutinin (PHA)-induced transformation of lymphocytes from patients with cancer.

Authors:  R M Sutherland; W R Inch; J A McCredie
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

View more
  2 in total

1.  Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.

Authors:  M Gereis; A P Burford-Mason; S M Watkins
Journal:  Agents Actions       Date:  1987-12

2.  Phytohaemagglutinin responsiveness of peripheral lymphocytes and survival in patients with primary breast cancer.

Authors:  A Burford-Mason; G M Gyte; S M Watkins
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.